Pharmaceutical Industry

Page 3 of 100

A man leans over and reaches for a bottle while standing in front of a shelf on medications.
Economy

Tariffs threaten a pharmaceuticals shortage, as 95% of ibuprofen comes from China

By
April 30, 2025
People walking by Viagra Connect ad seen in The Boots Pharmacy window in Dublin during Level 5 Covid-19 lockdown. On Thursday, 28 January, 2021, in Dublin, Ireland.
Politics

Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.

By
April 30, 2025
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
Finance

AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat

By
April 29, 2025
Pharma giant Merck expects Trump’s tariffs to cost the company $200 million
Health

Pharma giant Merck expects Trump’s tariffs to cost the company $200 million

By Maia Anderson and Healthcare Brew
April 25, 2025
A man walks next to a sign for the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Before US President Donald Trump postponed a range of imminent tariffs, Switzerland was facing a daunting 31% levy on most Swiss goods to imported to the United States, a higher rate than would have been imposed on European Union countries. Such a tariff would've been high damaging to iconic Swiss industries like chocolate and watchmaking. The reprieve will provide breathing room for Swiss officials looking to negotiate a deal with the US, although Swiss goods will still face a 10% tariff in the meantime, and the fate of a potential separate tariff on pharmaceuticals is unknown.
Health

Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.

By
April 22, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
Retail

Novo Nordisk slides on pressure from Lilly’s pill study

By Marthe Fourcade and Bloomberg
April 22, 2025
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
Politics

Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips

By Elaine Kurtenbach and The Associated Press
April 15, 2025
LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
Health

Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs

By
April 9, 2025
The Ha'penny Bridge is a pedestrian bridge built in 1816 over the River Liffey in Dublin, Ireland.
Finance

Could Trump tariffs solve Ireland’s housing crisis?

By
April 8, 2025
Stock market numbers are displayed on the floor of the New York Stock Exchange during morning trading on April 03, 2025 in New York City. (Photo: Michael M. Santiago/Getty Images)
Newsletters

How Trump’s import tariffs shocked tech stocks

By
April 4, 2025
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
Retail

Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics

By
April 3, 2025
Recursion’s automated high throughput wet lab
Features

Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

By
April 3, 2025
Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
Leadership

GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

By
April 2, 2025
Photo of Mark Cuban
Health

Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers

By
April 1, 2025
Katherine Stueland
Tech

As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company

By
March 31, 2025

Most Popular